Treat-to-target and Improving Outcomes in Psoriasis: A Report from the GRAPPA 2014 Annual Meeting

被引：4

作者：

Takeshita, Junko ^{[1
,2
]}

Armstrong, April W. ^{[3
]}

Mease, Philip J. ^{[4
]}

Gelfand, Joel M. ^{[5
]}

机构：

[1] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA

[3] Univ Colorado, Colorado Hlth Outcomes Program COHO, Denver, CO 80202 USA

[4] Swedish Med Ctr, Seattle, WA USA

[5] Univ Washington, Sch Med, Seattle, WA USA

来源：

JOURNAL OF RHEUMATOLOGY | 2015年 / 42卷 / 06期

关键词：

PSORIASIS; PSORIATIC ARTHRITIS; TREAT-TO-TARGET; OUTCOMES; PHYSICIAN GLOBAL ASSESSMENT; MYOCARDIAL-INFARCTION; RHEUMATOID-ARTHRITIS; INCREASED RISK; TIGHT CONTROL; MODERATE; SEVERITY; THERAPY; DISEASE; INDEX;

D O I：

10.3899/jrheum.150128

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Treat-to-target strategies are part of routine clinical practice in cardiovascular medicine. This approach, however, is relatively new in rheumatology and dermatology and has not been widely applied to the management of psoriatic diseases. At the 2014 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) in New York, New York, USA, several GRAPPA members summarized and participated in a panel discussion on the treat-to-target concept as it applies to psoriasis, its potential role in improving treatment outcomes, identification of specific treatment targets for psoriasis, and future directions for research.

引用

页码：1037 / 1040

页数：4

共 39 条

[1] The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study [J].

Abuabara, K. ;

Lee, H. ;

Kimball, A. B. .

BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (05) :1066-1073

[2] Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study [J].

Ahlehoff, O. ;

Skov, L. ;

Gislason, G. ;

Lindhardsen, J. ;

Kristensen, S. L. ;

Iversen, L. ;

Lasthein, S. ;

Gniadecki, R. ;

Dam, T. N. ;

Torp-Pedersen, C. ;

Hansen, P. R. .

JOURNAL OF INTERNAL MEDICINE, 2013, 273 (02) :197-204

[3]

[Anonymous], CAN GUID MAN PLAQ PS

[4]

[Anonymous], J DERMATOLOG TREAT

[5] Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies [J].

Armstrong, Ehrin J. ;

Harskamp, Caitlin T. ;

Armstrong, April W. .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (02) :e000062

[6] Quality of life measures in psoriasis: a critical appraisal of their quality [J].

Ashcroft, DM ;

Po, ALW ;

Williams, HC ;

Griffiths, CEM .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (05) :391-398

[7] Increased Risk of Diabetes Mellitus and Likelihood of Receiving Diabetes Mellitus Treatment in Patients With Psoriasis [J].

Azfar, Rahat S. ;

Seminara, Nicole M. ;

Shin, Daniel B. ;

Troxel, Andrea B. ;

Margolis, David J. ;

Gelfand, Joel M. .

ARCHIVES OF DERMATOLOGY, 2012, 148 (09) :995-1000

[8] Treatment goals for moderate to severe psoriasis: An Australian consensus [J].

Baker, Christopher ;

Mack, Alexandra ;

Cooper, Alan ;

Fischer, Gayle ;

Shumack, Stephen ;

Sidhu, Shireen ;

Soyer, Peter ;

Wu, Jason ;

Chan, Jonathan ;

Nash, Peter ;

Rawlin, Morton ;

Radulski, Barbara ;

Foley, Peter .

AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2013, 54 (02) :148-154

[9] Assessing Psoriasis Severity and Outcomes for Clinical Trials and Routine Clinical Practice [J].

Chalmers, Robert J. G. .

DERMATOLOGIC CLINICS, 2015, 33 (01) :57-+

[10] Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: A nationwide cohort study [J].

Chen, Yi-Ju ;

Chang, Yun-Ting ;

Shen, Jui-Lung ;

Chen, Tzu-Ting ;

Wang, Chang-Bi ;

Chen, Chuan-Mu ;

Wu, Chun-Ying .

ARTHRITIS AND RHEUMATISM, 2012, 64 (06) :1879-1887

← 1 2 3 4 →